The therapeutic effect of nizatidine was mediated by two complementary mechanisms:Hepatocytes/parenchymal cancer cells: we demonstrate that the HRH2/CREB5 signaling pathway is perturbed in hepatocytes during liver injury. The gene discussed is CREB5; the disease is cancer.